Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Gastrointestinal Cancer Treatment
Created with Pixso. Regorafenib Tablets 40mg 28 Tablets Box Oral Multi Kinase Inhibitor for Metastatic Colorectal Cancer GIST HCC Therapy

Regorafenib Tablets 40mg 28 Tablets Box Oral Multi Kinase Inhibitor for Metastatic Colorectal Cancer GIST HCC Therapy

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Regorafenib KL-20244635
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

Oral Multi Kinase CRC Therapy

,

VEGFR TIE2 CSF1R Inhibitor

,

Third Line mCRC GIST HCC Drug

Product Description

瑞戈非尼 40毫克 x 28片

[产品名称]

通用名:瑞戈非尼

品牌名称:科菲吉

规格:40毫克 x 28片

[活性成分]

瑞戈非尼

【适应症】

1. 接受标准治疗后的转移性结直肠癌.2. 接受伊马替尼和舒尼替尼治疗后的晚期胃肠道间质瘤.3. 接受索拉非尼治疗后的晚期肝细胞癌.

[作用机制]

口服多激酶抑制剂,靶向血管生成激酶(VEGFR1-3,TIE2),基质激酶(PDGFR-b,FGFR)和致癌激酶(c-KIT,RET,RAF,BRAF V600E).

[剂量]

每日一次,每次160毫克(4片),28天为一个周期,服用21天,停用7天.低脂餐后服用.

【不良反应】

手足皮肤反应(53%),腹泻,疲劳,高血压,肝毒性,感染.出血,胃肠道穿孔,心肌缺血.

[贮存]

请存放于30摄氏度以下.请将本品放在儿童不能接触的地方.

[保质期]

24个月

批准号:H20244635